Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS3527220 A
Tipo de publicaciónConcesión
Fecha de publicación8 Sep 1970
Fecha de presentación28 Jun 1968
Fecha de prioridad28 Jun 1968
Número de publicaciónUS 3527220 A, US 3527220A, US-A-3527220, US3527220 A, US3527220A
InventoresSummers George Donald
Cesionario originalFairchild Hiller Corp
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Implantable drug administrator
US 3527220 A
Resumen  disponible en
Imágenes(1)
Previous page
Next page
Reclamaciones  disponible en
Descripción  (El texto procesado por OCR puede contener errores)

United States Patent Inventor George Donald Summers Stony Brook, New York Appl. No. 741,117

Filed June 28, 1968 Patented Sept. 8, 1970 Assignee Fairchlld Hiller Corporation Farmingdale, 12.1., New York a corporation of Maryland IMPLANTABLE DRUG ADMINISTRATOR 15 Claims, 5 Drawing Figs.

U.S. Cl 128/260, 3/1, 128/15, 128/273 Int. Cl. A61m 7/00 Field of Search 128/260,

[561 References Cited UNITED STATES PATENTS 2,625,158 1/1953 Lee et a1. 128/260 3,313,289 4/1967 Kapra1.... 3/1 3,443,561 5/1969 Reed 128/260 Primary Examiner-Adele M. Eager Attorney-Michael W. York ABSTRACT: An implantable drug administrator comprises a bladder having a self-sealing port through which it can be filled with a drug, a pump for selectively pumping the drug 7 from the bladder into any desired area of the body, and an indicator for indicating when the desired amount of the drug has been injected.

Patented Sept. 8, 1970 v 3,527,220

INVENTOR GEORGE DONALD SUMMERS ATTORNEYS IMPLANTABLE DRUG ADMINISTRATOR This invention relates to a device which can be implanted within an animal body for administering drugs or the like.

It has been proposed to implant a reservoir containing a drug or other medical preparation within a body cavity for purposes of administering the drug. to an animal. In such arrangements, the drug is generally permitted to escape into the body through perforations in the container or by diffusion through the container itself.

The prior art devices for this purpose have only attained limited utility principally because of their lack of reliability due, at least in part, to clogging of the container, and the obvious inconvenience of replacing an implantable container every time its drug supply is exhausted. Further drawbacks are the inability to situate the container in any desired area of the body while releasing the drug in a distant area ofthe body, and the lack of a practical monitoring device for assuring the proper operation of the system.

The present invention provides an improved implantable drug administration system which avoids the foregoing drawbacks and therefore is more reliable, easier to use, and of wider utility than known devices of this type.

Briefly, according to the invention, a drug is pumped from an implanted bladder by means of an implanted pump which is powered by an extra-corporeal magnetic field. The bladder includes a self-sealing port through which it can be refilled whenever desired. An implanted light source indicates the rate at which the drug is being pumped and thus can also be used to indicate the total dosage administered.

In the drawings:

FIG. 1 is a diagrammatic view showing how the invention typically would be implanted within the body ofa human;

FIG. 2 is a perspective view of the invention prior to being implanted;

FIG. 3 is a circuit diagram of the indicator circuit used in the preferred embodiment of the invention;

FIG. 4 is a detailed cross-sectional view of the inlet tube of the invention illustrated in FIG. 2; and

FIG. 5 is a detailed broken sectional view of the switch and the pump ofthe invention illustrated in FIG. 2.

In the specification and claims, the term "drug" is used in the broadest sense and includes all therapeutic and diagnostic agents such as hormones, vitamins, antibiotics, anticoagulants, cancericidal and spermicidal agents, vasoactive agents, and all other substances used to control, treat, or diagnose, or otherwise affect, physical or mental conditions (normal and abnormal) existing in and/or on an animal body.

Referring to FIGS. 1 and 2, the invention is shown as comprising a bladder and a pump 12 having an inlet line 14 connected to the lowermost point of bladder 10. The bladder 10 and pump 12 may be sutured in place within the abdominal cavity 16 of an individual, with a pump outlet line 18 leading into that portion of the body where it is desired to administer the drug.

Bladder 10 includes a port 20 which is self sealing and readily accessible from outside the individuals body although the port may be underneath the skin. A miniature light source 22 is sewn to bladder 10 within abdominal cavity 16, and, when energized, can be observed through the individuals skin. As explained below, light source 22 provides an indication of the dosage or amount of the drug within bladder 10 administered by the pump 12.

In the preferred embodiment of the invention, pump 12 is of the type disclosed in the May/June 1967 issue of The Journal of the Association for the Advancement of Medical Instrumentation, in an article entitled A New Miniature Pump for the Treatment of Hydrocephalus" by Summers and Mathews. As explained in that article, pump 12 includes a rotor assembly which is coupled through a gear train to a rotatable magnetic disc. The rotor contains three peripheral rollers which cyclically compress a length of tubing between the pump inlet 14 and outlet l8 with a peristatic action, thereby forcing fluid from inlet 14 to outlet 18. Since this construction is known, it is not illustrated and described here in detail.

The pump is driven by a rotatable magnet 24 located outside the body and rotated by a motor 26 suitably coupled thereto. The rotation of magnet 24 rotates the pump magnet by the pull of its magnetic field thus pumping the drug from bladder 10 through pump inlet tube 14 and outlet tube 18. This particular pump is highly desirable since it can be powered without penetrating the skin (exclusive of implantation), the advantages of which are self-evident. The specific pump per se, however, forms no part of this invention. The manner in which the invention is employed is obvious from the preceding explanation. After the bladder 10 and pump 12 have been implanted, the drug to be administered is injected into the bladder by means of a hypodermic needle and syringe or the like inserted through the seal-sealing plug 20. Thereafter, whenever it is desired to administer the drug, the motor 26 is energized to rotate magnet 24 thus driving pump 12 as explained above. The operation of the pump will cause the drug within bladder 10 to be administered through the distal end of outlet tube 18 wherever it is positioned.

The light source 22 may be energized a predetermined number of times during each revolution of the pump rotor to indicate that the pump is operating and to provide a measure of the dosage administered.

FIG. 2 shows certain specific details of the bladder 10, pump 12 and the energizing means for lamp 22. The pump is retained within a sealed stainless steel (or plastic) casing 30 which includes a flange 32 having apertures 34 by means of which the pump may be sewn into the body. A coil 36 is wrapped around a diameter of casing 30, with the coil leads 37 and 38 coupled, respectively to a miniature switch 40 within casing 30 and to the-lamp 22. Switch 40 (shown diagrammatically in FIG. 3) is a single-pole, single-throw (normally open) switch which can be closed in any suitable fashion each time a roller of the pump rotor traverses the pump tubing between inlet 14 and outlet 18. The operation of a preferred embodiment of switch 40 is explained below with reference to FIG. 5.

When the magnet 24 is rotated by motor 26, the resultant rotating magnetic field intersects coil 36 inducing a current in the coil. Accordingly, each time the contacts of switch 40 are closed, an energizing current is coupled to the light source 22. Thus, the energization of the light, which can be seen through the skin, indicates that the pump is operating properly. Since the volume amount of the drug displaced between successive rollers by rotation of the pump rotor is known, the flashes of light source 22 can be counted to measure the total administered dosage of the drug.

The bladder 10 includes an inner layer 50 coated with an outer layer 52 which is compatible with animal tissue. Various silicone rubber compositions are suitable for use as layer 52, representative examples being given in US Pat. No. 3,279,996 of Long. Since diffusion may occur through a silicone rubber layer, the inner layer 50 must be impervious to and not degraded by the drug used. Standard latex rubber is suitable for many purposes as the material of inner layer 50. The use of the silicone rubber layer provides a degree of selfsealing in the event the bladder is accidentally punctured during filling.

The self-sealing port 20 comprises a ring 54 made of a tissue compatible material such as a polycarbonate resin or stainless steel filled with a silicone rubber material 56 to a depth of about .25 inches. If necessary, an inner layer (not shown) of a material impervious to the drug may be used. The raised ring 54 enables the doctor to locate the port 20 through the skin. Where ring 54 is made of magnetically permeable material it can be located by a common stud finder or the like.

A stiff plastic or metal striker plate 58 is bonded to the interior layer 50 opposite port 20 as protection against accidental puncture of the bladder during injection of the drug. To ensure injection of the drug into the bladder, the inner surface of the port may be made concave so that there will always be a space between the port and striker plate 58.

As noted previously, the invention is not limited to any specific drug, and the drugs may be administered directly into tissue, organs, muscle, or body fluid (including blood). The

particular function in this respect will determine the size and construction of the needle or other termination of the outlet tube 18. As a specific example tube 18 may terminate in a rounded end 62 having side slots 64 through which the drug is dispensed. This construction will tend to prevent body fluid from entering tube 18 without interfering with the exit of the drug. A woven tube 66 (for example, of Dacron) may be bonded to the exterior surface of tube 18. Animal tissue will grow into tube 66 to help anchor the tube in the desired area of the body and to seal the penetration site against flow of body fluids.

The light source may comprise a diode made of gallium arsenide phosphide, requiring a forward bias of about 1.5 to 2.0 volts. It is less than a tenth of an inch in diameter and has an overall length of about an eighth of an inch, including the lens cap. It is rated at 50 foot-Lamberts brightness at a forward bias of 1.65 volts and forward current of 50 milliamperes. At that voltage it has a continuous forward current rating of 100 milliamperes.

In order to achieve maximum optical transmission through the skin, it is desirable to choose a wavelength in the zone of greatest skin transparency. However, this wavelength would be unsuitable as maximum transparency lies in the near-infrared region and is not visible to the human eye. On the other hand, the region of maximum sensitivity of the light-adapted human eye, about 570 millimicrons, is poorly transmitted through the skin. The wavelength of the selected lightemitting diode, in the 600-to-700 millimicron region, provides a compromise. The skin is reasonably transparent at this wavelength and the eye can easily detect the rich red color.

Some data on the depth of penetration of optical frequencies into the human have been reported. Penetration depth varies with skin pigmentation and is in the range of about two millimeters maximum. Data for transmission outward is not available, but in experiments the diode-emitted light was easily visible in a darkened room through chicken skin and tissue for depths of more than 8 millimeters. I

The energizing circuit for light source 22 is shown in FIG. 3. It is a simple series circuit and also includes a protective diode 70 which prevents the application of excessive back voltages to the light source 22.

In place of the coil 36, the power to operate lamp 22 may be provided by a battery or photo-voltaic cells. Also the coil 36 may be made responsive to an inductive or RF electromagnetic field.

In the preferred embodiment of the invention, the electrical leads are covered with an insulating material 72 (FIG. 4) such as Teflon and the solder joints coated with an epoxy (not shown). The wires are then bonded to the inlet tube 14 and the entire construction coated with a suitable silicone rubber composition 74.

A preferred construction for switch 40 is shown in FIG. 5. The pump includes a steel ring 80 within the pump casing 30. The pump rollers (one of which is shown at 82) compress the tubing 84 between inlet and outlet tubes 14 and 18 against ring 80. Switch 40 thus comprises the ring 80, a pressure sensitive paint 86, and a terminal 88 which is insulated from ring 80. The switch leads 37 and 37 are mechanically coupled through casing 30 (and suitably sealed) into electrical contact with ring 80 and terminal 88, respectively.

Paint 86 is ofa type which undergoes an increase in conductivity upon application of pressure thereto. (A suitable paint of this type is manufactured by Clark Electronics Laboratories of Palm Springs, California and sold under the trademark Micro-Ducer (type 9A).) Thus, each time a roller 82 passes over the terminal 88, the resultant increase in pressure closes" switch 40 to energize the light source 22.

Obviously, other switch constructions may be employed with the invention. A magnetically actuated mechanical switch would be of particular utility since it would enable a simple means for testing whether the signalling system was in proper working order by applying an external magnetic field to latch the switch in its closed condition. If, because of the magnetic fields required to operate pump 12, such a switch could not be employed in place of switch 40, a normally open switch of this type could be located at the bladder 10 and placed electrically in parallel with the contacts of switch 40. Such a switch is shown in dotted lines at in FIG. 3.

The visual signalling system of the invention would have utility in other applications apart from the specific case herein illustrated. For example, it could be used to test the continuity of circuits where breakage or interruption of leads is a problem (as with cardiac pacemakers).

Use of the invention is specifically contemplated in the treatment of diabetics or for chemotherapy of a carcinomatic condition. It could be used for the daily administration of a contraceptive, in the treatment of Hansens disease and in the administration of some hormones..The invention, however, is not in any respect limited as to its utility in special situations.

It is intended that the various parts of the invention will be sealed and coated with a tissue compatible material (such as silicone rubber) to whatever extent is required. Since silicone rubber is not a sealant, it may be necessary or desirable to coat the parts with a sealant (e.g. an epoxy) prior to applying the silicone rubber coating.

The invention can be used in many different ways to inject varying amounts of a drug ranging, for example, from microliters per day to milliliters per day. It can be used continuously and, conceivably, actuation of the pump may be made automatically responsive to a measurable body condition (e.g. oxygen partial pressure in the blood) or responsive to a programmed time schedule. The pump rotor can be made to rotate in both directions whereby a single pump can be used in conjunction with two bladders (and suitable valves) to selectively pump drugs from either bladder.

Iclaim:

1. An implantable drug administrator for injecting a drug into an animal body comprising a bladder adapted to be implanted in the body having self-sealing means for permitting a drug to be injected into the interior of said bladder and a pump adapted to be implanted in the body for pumping the drug from said bladder, said pump having an inlet connected to said bladder and an outlet adapted to be positioned within said body.

2. An implantable drug administrator according to claim 1 wherein said self-sealing means comprises a port.

3. An implantable drug administrator according to claim 2 wherein said port includes a protruding ring.

4. An implantable drug administrator according to claim 2 including a striker plate bonded to said bladder in the area beneath said port.

5. An implantable drug administrator according to claim 2 wherein said port includes a magnetically permeable material.

6. An implantable drug administrator according to claim 1 including means connected to said pump for indicating the rate at which said pump is operating.

7. An implantable drug administrator according to claim 6 including means for testing the operation of said indicator means.

8. An implantable drug administrator according to claim 6 wherein said indicating means includes a coil for producing a current in response to a field exterior of said body.

9. An implantable drug administrator according to claim 8 wherein said pump is adapted to be operated by a magnetic field and said coil is wound around said pump to intersect said magnetic field.

- 10. An implantable drug administrator according to claim 8 wherein said indicating means includes a light source connected in circuit with said coil.

11. An implantable drug administrator according to claim 10 including a switch connected in circuit with said coil and said light source, said switch being adapted to be activated in response to the operation of said pump.

12. An implantable drug administrator according to claim 11 wherein said pump includes a rotor, and said switch is adapted to be activated by said rotor.

13. An implantable drug administrator according to claim 12 wherein said pump includes an outer casing and said switch is mounted within said casing.

14. An implantable drug administrator according to claim

Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US3604417 *31 Mar 197014 Sep 1971American Cyanamid CoOsmotic fluid reservoir for osmotically activated long-term continuous injector device
US3640269 *24 Oct 19698 Feb 1972Delgado Jose M RFluid-conducting instrument insertable in living organisms
US3692027 *23 Abr 197119 Sep 1972Ellinwood Everett H JrImplanted medication dispensing device and method
US3730186 *5 Mar 19711 May 1973Univ CalifAdjustable implantable artery-constricting device
US3731669 *16 Oct 19708 May 1973Sander Nuclear CorpExternal implantation of energy to power internal devices
US3731681 *14 Ene 19728 May 1973Univ MinnesotaImplantable indusion pump
US3750194 *16 Mar 19717 Ago 1973Fairchild IndustriesApparatus and method for reversibly closing a natural or implanted body passage
US3757846 *12 Abr 197111 Sep 1973Herman HMethod and apparatus for effecting electromagnetic displacement of fluids
US3765414 *10 Mar 197216 Oct 1973Hydro Med Sciences IncDrug release system
US3783868 *6 May 19718 Ene 1974Gulf Oil CorpPercutaneous implant
US3796217 *17 May 197312 Mar 1974Hydr Med Sciences IncDrug release system
US3831583 *5 Feb 197327 Ago 1974Univ CalifImplantable bulb for inflation of surgical implements
US3923060 *23 Abr 19742 Dic 1975Jr Everett H EllinwoodApparatus and method for implanted self-powered medication dispensing having timing and evaluator means
US3971376 *2 Oct 197427 Jul 1976Ceskoslovenska Akademie VedMethod and apparatus for introducing fluids into the body
US3996933 *4 Oct 197514 Dic 1976Morton GutnickIntrauterine contraceptive devices and processes
US4013074 *6 Abr 197622 Mar 1977Siposs George GImplantable medication-dispensing device
US4041954 *7 May 197516 Ago 1977Kabushiki Kaisha Daini SeikoshaSystem for detecting information in an artificial cardiac pacemaker
US4102998 *1 Jul 197625 Jul 1978Morton GutnickProcess for the prevention of venereal disease
US4133302 *29 Abr 19779 Ene 1979The Commonwealth Industrial Gases LimitedInfant incubator
US4146029 *31 May 197727 Mar 1979Ellinwood Jr Everett HSelf-powered implanted programmable medication system and method
US4152098 *3 Ene 19771 May 1979Clark Ivan PMicropump
US4221219 *31 Jul 19789 Sep 1980Metal Bellows CorporationImplantable infusion apparatus and method
US4253201 *24 May 19793 Mar 1981Ross David AProsthesis with self-sealing valve
US4265241 *28 Feb 19795 May 1981Andros IncorporatedImplantable infusion device
US4445826 *22 Ene 19821 May 1984Polaroid CorporationPeristaltic pump apparatus
US4604090 *22 Nov 19835 Ago 1986Consolidated Controls CorporationCompact implantable medication infusion device
US4615691 *8 Dic 19837 Oct 1986Salomon HakimSurgically-implantable stepping motor
US4677982 *29 Mar 19847 Jul 1987New York UniversityInfrared transcutaneous communicator and method of using same
US4687468 *25 Jul 198618 Ago 1987Cook, IncorporatedImplantable insulin administration device
US4692147 *19 Jul 19858 Sep 1987Medtronic, Inc.Drug administration device
US4710177 *15 May 19861 Dic 1987Smith Robert RSubcutaneous ventricular injection apparatus and method
US4747832 *16 May 198631 May 1988Jacques BuffetDevice for the injection of fluid, suitable for implantation
US4772257 *7 Oct 198620 Sep 1988Salomon HakimExternal programmer for magnetically-adjustable cerebrospinal fluid shunt valve
US4816016 *18 Mar 198828 Mar 1989Pudenz-Schulte Medical Research Corp.Subcutaneous infusion reservoir and pump system
US4820273 *1 Mar 198811 Abr 1989Eaton CorporationImplantable medication infusion device and bolus generator therefor
US4840190 *14 Abr 198820 Jun 1989Dow Corning WrightLozenge-shaped low profile injection reservoir
US4884013 *15 Ene 198828 Nov 1989Sherwood Medical CompanyMotor unit for a fluid pump and method of operation
US5061243 *8 Feb 198929 Oct 1991Baxter International Inc.System and apparatus for the patient-controlled delivery of a beneficial agent, and set therefor
US5085644 *20 May 19914 Feb 1992Pudenz-Schulte Medical Research CorporationSterilizable medication infusion device with dose recharge restriction
US5152753 *2 Abr 19906 Oct 1992Pudenz-Schulte Medical Research CorporationMedication infusion device with dose recharge restriction
US5762599 *2 May 19949 Jun 1998Influence Medical Technologies, Ltd.Magnetically-coupled implantable medical devices
US6458118 *23 Feb 20001 Oct 2002Medtronic, Inc.Drug delivery through microencapsulation
US648546224 Ago 200026 Nov 2002Science IncorporatedFluid delivery device with heat activated energy source
US65824181 Jun 200024 Jun 2003Medtronic, Inc.Drug pump with reinforcing grooves
US659257124 May 200015 Jul 2003Medtronic, Inc.Drug pump with suture loops flush to outer surface
US671973927 Ago 200113 Abr 2004Medtronic, Inc.System and method for attaching upper and lower outer cases in an implantable drug pump
US698675131 Oct 200317 Ene 2006Cabg Medical, Inc.Grafted network incorporating a multiple channel fluid flow connector
US69916152 Ago 200431 Ene 2006Cabg Medical, Inc.Grafted network incorporating a multiple channel fluid flow connector
US70116435 Ago 200314 Mar 2006Cabg Medical, Inc.Grafted network incorporating a multiple channel fluid flow connector
US734157730 Abr 200311 Mar 2008Renishaw PlcImplantable drug delivery pump
US73611684 Ago 200422 Abr 2008Acclarent, Inc.Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US741048023 Sep 200512 Ago 2008Acclarent, Inc.Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US74194974 Oct 20062 Sep 2008Acclarent, Inc.Methods for treating ethmoid disease
US754732329 Ago 200616 Jun 2009Sinexus, Inc.Stent for irrigation and delivery of medication
US772052126 Abr 200518 May 2010Acclarent, Inc.Methods and devices for performing procedures within the ear, nose, throat and paranasal sinuses
US778531512 Dic 200731 Ago 2010Acclarent, Inc.Methods for irrigation of ethmoid air cells and treatment of ethmoid disease
US78625028 Jun 20074 Ene 2011Ellipse Technologies, Inc.Method and apparatus for adjusting a gastrointestinal restriction device
US796780625 Mar 200428 Jun 2011Medtronic, Inc.Method of delivering a fluid medication to a patient in flex mode
US796781222 Oct 200228 Jun 2011Medtronic, Inc.Drug infusion system programmable in flex mode
US798102528 Oct 200819 Jul 2011Ellipse Technologies, Inc.Adjustable implant and method of use
US808000030 Oct 200720 Dic 2011Acclarent, Inc.Methods and apparatus for treating disorders of the ear nose and throat
US808810126 Oct 20073 Ene 2012Acclarent, Inc.Devices, systems and methods for treating disorders of the ear, nose and throat
US809043330 Oct 20073 Ene 2012Acclarent, Inc.Methods and apparatus for treating disorders of the ear nose and throat
US81009338 May 200824 Ene 2012Acclarent, Inc.Method for treating obstructed paranasal frontal sinuses
US81140621 Oct 200914 Feb 2012Acclarent, Inc.Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US81141134 Oct 200514 Feb 2012Acclarent, Inc.Multi-conduit balloon catheter
US811875730 Abr 200721 Feb 2012Acclarent, Inc.Methods and devices for ostium measurement
US812372229 Oct 200728 Feb 2012Acclarent, Inc.Devices, systems and methods for treating disorders of the ear, nose and throat
US81424224 Mar 200827 Mar 2012Acclarent, Inc.Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
US814640031 Jul 20073 Abr 2012Acclarent, Inc.Endoscopic methods and devices for transnasal procedures
US817282830 Oct 20078 May 2012Acclarent, Inc.Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US818243210 Mar 200822 May 2012Acclarent, Inc.Corewire design and construction for medical devices
US819038917 May 200629 May 2012Acclarent, Inc.Adapter for attaching electromagnetic image guidance components to a medical device
US82465338 Jun 200721 Ago 2012Ellipse Technologies, Inc.Implant system with resonant-driven actuator
US82775037 May 20092 Oct 2012Intersect Ent, Inc.Stent for irrigation and delivery of medication
US82775047 May 20092 Oct 2012Intersect Ent, Inc.Stent for irrigation and delivery of medication
US831781630 Sep 200227 Nov 2012Acclarent, Inc.Balloon catheters and methods for treating paranasal sinuses
US838864229 Ago 20085 Mar 2013Acclarent, Inc.Implantable devices and methods for treating sinusitis and other disorders
US841447316 Sep 20099 Abr 2013Acclarent, Inc.Methods and apparatus for treating disorders of the ear nose and throat
US842545729 Dic 200923 Abr 2013Acclarent, Inc.Devices, systems and methods for diagnosing and treating sinusitus and other disorder of the ears, nose and/or throat
US843529024 Mar 20107 May 2013Acclarent, Inc.System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx
US843968729 Dic 200614 May 2013Acclarent, Inc.Apparatus and method for simulated insertion and positioning of guidewares and other interventional devices
US848065521 Jun 20119 Jul 2013Medtronic, Inc.Drug infusion system programmable in flex mode
US84851998 May 200716 Jul 2013Acclarent, Inc.Methods and devices for protecting nasal turbinate during surgery
US8545255 *23 Abr 20101 Oct 2013Centre Hospitalier Universitaire De RouenSubcutaneous device for electrical percutaneous connection
US863935323 Abr 201028 Ene 2014Centre Hospitalier Universitaire De RouenElectrical connection device implantable in the human body
US870262629 Dic 200622 Abr 2014Acclarent, Inc.Guidewires for performing image guided procedures
US871515910 Jun 20116 May 2014Ellipse Technologies, Inc.Adjustable implant and method of use
US871516930 Oct 20076 May 2014Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US872159123 Ene 201213 May 2014Acclarent, Inc.Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US87409296 Feb 20023 Jun 2014Acclarent, Inc.Spacing device for releasing active substances in the paranasal sinus
US874738924 Abr 200710 Jun 2014Acclarent, Inc.Systems for treating disorders of the ear, nose and throat
US876470930 Jun 20101 Jul 2014Acclarent, Inc.Devices, systems and methods for treating disorders of the ear, nose and throat
US876472618 Ago 20091 Jul 2014Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US876472922 Dic 20081 Jul 2014Acclarent, Inc.Frontal sinus spacer
US87647869 Oct 20121 Jul 2014Acclarent, Inc.Balloon catheters and methods for treating paranasal sinuses
US877792615 Mar 201315 Jul 2014Acclarent, Inc.Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasel or paranasal structures
US880816311 Oct 201219 Ago 2014Ellipse Technologies, Inc.Adjustable implant and method of use
US882804118 Mar 20109 Sep 2014Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US88521437 Abr 20107 Oct 2014Acclarent, Inc.Devices, systems and methods for treating disorders of the ear, nose and throat
US885858618 Ene 200714 Oct 2014Acclarent, Inc.Methods for enlarging ostia of paranasal sinuses
US88647879 Abr 200821 Oct 2014Acclarent, Inc.Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis
US887089329 Abr 201028 Oct 2014Acclarent, Inc.Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
US889461416 Feb 200625 Nov 2014Acclarent, Inc.Devices, systems and methods useable for treating frontal sinusitis
US890592226 Mar 20129 Dic 2014Acclarent, Inc.Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
US893227616 May 200713 Ene 2015Acclarent, Inc.Shapeable guide catheters and related methods
US894508828 Abr 20103 Feb 2015Acclarent, Inc.Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US895122518 May 200610 Feb 2015Acclarent, Inc.Catheters with non-removable guide members useable for treatment of sinusitis
US896139831 Oct 200724 Feb 2015Acclarent, Inc.Methods and apparatus for treating disorders of the ear, nose and throat
US896149529 Oct 200724 Feb 2015Acclarent, Inc.Devices, systems and methods for treating disorders of the ear, nose and throat
US896826918 Ene 20123 Mar 2015Acclarent, Inc.Multi-conduit balloon catheter
US897988830 Jul 200917 Mar 2015Acclarent, Inc.Paranasal ostium finder devices and methods
US90396573 Sep 200926 May 2015Acclarent, Inc.Implantable devices and methods for delivering drugs and other substances to treat sinusitis and other disorders
US903968021 Abr 200826 May 2015Acclarent, Inc.Implantable devices and methods for delivering drugs and other substances to treat sinusitis and other disorders
US905044022 Sep 20069 Jun 2015Acclarent, Inc.Multi-conduit balloon catheter
US905596522 Mar 201016 Jun 2015Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US90726266 May 20137 Jul 2015Acclarent, Inc.System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx
US908487615 Mar 201321 Jul 2015Acclarent, Inc.Implantable devices and methods for delivering drugs and other substances to treat sinusitis and other disorders
US908925815 Mar 200728 Jul 2015Acclarent, Inc.Endoscopic methods and devices for transnasal procedures
US910138416 Ene 200911 Ago 2015Acclarent, Inc.Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
US91075748 Dic 201118 Ago 2015Acclarent, Inc.Endoscopic methods and devices for transnasal procedures
US915549224 Sep 201013 Oct 2015Acclarent, Inc.Sinus illumination lightwire device
US916796131 Oct 200727 Oct 2015Acclarent, Inc.Methods and apparatus for treating disorders of the ear nose and throat
US91798235 Jun 200910 Nov 2015Acclarent, Inc.Methods and devices for facilitating visualization in a surgical environment
US919873619 Abr 20121 Dic 2015Acclarent, Inc.Adapter for attaching electromagnetic image guidance components to a medical device
US922087930 Abr 201429 Dic 2015Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US924183421 Mar 201426 Ene 2016Acclarent, Inc.Devices, systems and methods for treating disorders of the ear, nose and throat
US926540731 Jul 200723 Feb 2016Acclarent, Inc.Endoscopic methods and devices for transnasal procedures
US927185725 Mar 20151 Mar 2016Ellipse Technologies, Inc.Adjustable implant and method of use
US928958413 Sep 201122 Mar 2016The University Of British ColumbiaRemotely controlled drug delivery systems
US93083614 Mar 201312 Abr 2016Acclarent, Inc.Implantable devices and methods for treating sinusitis and other disorders
US93396365 Sep 201317 May 2016Mubashir H KhanSubcutaneous fluid pump
US935175016 Dic 200931 May 2016Acclarent, Inc.Devices and methods for treating maxillary sinus disease
US93706495 Feb 201521 Jun 2016Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US93991211 Jul 200926 Jul 2016Acclarent, Inc.Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US943343715 Mar 20136 Sep 2016Acclarent, Inc.Apparatus and method for treatment of ethmoid sinusitis
US94571754 Sep 20154 Oct 2016Acclarent, Inc.Balloon catheters and methods for treating paranasal sinuses
US946306818 Jun 201311 Oct 2016Acclarent, Inc.Methods and devices for protecting nasal turbinates
US946836219 Abr 201218 Oct 2016Acclarent, Inc.Endoscopic methods and devices for transnasal procedures
US952665010 Jul 201427 Dic 2016Nuvasive Specialized Orthopedics, Inc.Adjustable implant and method of use
US955469114 May 200731 Ene 2017Acclarent, Inc.Endoscopic methods and devices for transnasal procedures
US957248019 Jun 201421 Feb 2017Acclarent, Inc.Methods and devices for facilitating visualization in a surgical environment
US96035065 Jun 200928 Mar 2017Acclarent, Inc.Methods and devices for facilitating visualization in a surgical environment
US961042816 Oct 20144 Abr 2017Acclarent, Inc.Devices, systems and methods useable for treating frontal sinusitis
US961577518 Ene 201211 Abr 2017Acclarent, Inc.Methods and devices for ostium measurements
US96296564 Sep 201525 Abr 2017Acclarent, Inc.Adapter for attaching electromagnetic image guidance components to a medical device
US96296845 Mar 201425 Abr 2017Acclarent, Inc.Apparatus and method for treatment of ethmoid sinusitis
US963625827 May 20152 May 2017Acclarent, Inc.System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx
US964947730 Abr 201416 May 2017Acclarent, Inc.Frontal sinus spacer
US965604916 Abr 201623 May 2017Mubashir H. KhanSubcutaneous fluid pump
US975040130 Jul 20145 Sep 2017Acclarent, Inc.Paranasal ostium finder devices and methods
US20030216714 *30 Abr 200320 Nov 2003Gill Steven StreatfieldPump
US20040077996 *22 Oct 200222 Abr 2004Jasperson Keith E.Drug infusion system with multiple medications
US20040077997 *22 Oct 200222 Abr 2004Jasperson Keith E.Drug infusion system programmable in flex mode
US20040181204 *25 Mar 200416 Sep 2004Jasperson Keith E.Method of delivering a fluid medication to a patient in flex mode
US20040228411 *16 Sep 200318 Nov 2004Sony CorporationMethod and system for decoder clock control in presence of jitter
US20040230182 *23 Dic 200318 Nov 2004Medtronic, Inc.Drug delivery through encapsulation
US20050033218 *31 Oct 200310 Feb 2005Villafana Manuel A.Grafted network incorporating a multiple channel fluid flow connector
US20050033219 *2 Ago 200410 Feb 2005Villafana Manuel A.Grafted network incorporating a multiple channel fluid flow connector
US20060106361 *23 Sep 200518 May 2006Acclarent, Inc.Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US20070073230 *16 Nov 200629 Mar 2007Medtronic, Inc.Drug infusions system with multiple medications
US20070083153 *28 Sep 200612 Abr 2007Hans-Peter HaarInfusion system for administration of a liquid medication
US20080097354 *29 Ago 200624 Abr 2008Francois LavigneStent for irrigation and delivery of medication
US20080304710 *8 Jun 200711 Dic 2008Lijie XuMethod and apparatus for processing image of at least one seedling
US20090275882 *7 May 20095 Nov 2009Francois LavigneStent for irrigation and delivery of medication
US20090275903 *7 May 20095 Nov 2009Francois LavigneStent for irrigation and delivery of medication
US20100198247 *7 Abr 20105 Ago 2010Acclarent, Inc.Devices, Systems and Methods for Treating Disorders of the Ear, Nose and Throat
US20110237861 *10 Jun 201129 Sep 2011Ellipse Technologies, Inc.Adjustable implant and method of use
US20120045918 *23 Abr 201023 Feb 2012Pierre-Yves LitzlerSubcutaneous device for electrical percutaneous connection
EP0140727A1 *14 Ago 19848 May 1985Jacques BuffetImplantable fluid injection device
EP0392566A1 *24 Sep 198517 Oct 1990Cook IncorporatedImplantable insulin administration device
EP1772162A1 *8 Oct 200511 Abr 2007Boehringer Mannheim GmbhInfusion system for delivery of a liquid drug
EP2288406A2 *22 Jun 20092 Mar 2011Yehoshua ShacharA magnetic breather pump and a method for treating a brain tumor using the same
EP2288406A4 *22 Jun 200920 Nov 2013Yehoshua ShacharA magnetic breather pump and a method for treating a brain tumor using the same
WO1980001755A1 *25 Feb 19804 Sep 1980Andros IncImplantable infusion device
WO2002017989A229 Ago 20017 Mar 2002Medtronic, Inc.System and method for attaching upper and lower outer cases in an implantable drug pump
Clasificaciones
Clasificación de EE.UU.604/153
Clasificación internacionalA61M5/142, F04B43/12
Clasificación cooperativaA61M5/14276, A61M2205/3515, F04B43/1238
Clasificación europeaF04B43/12F, A61M5/142P10